MedTrace Logo

The TRIMAXX Coronary Stent Trial

NCT00596661 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2008-10-15

No results posted yet for this study

Summary

The primary objective of the trial is to demonstrate the safety and feasibility of treating coronary artery lesions which have not been previously treated with the TRIMAXX Coronary stent system as compared to the reported results for commercially available non-drug eluting coronary stent systems which are indicated for the same treatments.

Conditions

Interventions

DEVICE

TriMaxx Coronary Stent placement

Angioplasty with coronary artery stent placement

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Alexandre Abizaid, MD · Instituto Dante Pazzanese de Cardioloigia, Sao Paulo, Brazil

  • Jeffery J Popma, MD · Brigham and Women's Hospital. Boston, Massachusetts, USA

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Primary Completion
2005-09-30
Completion
2005-09-30

Countries

  • Brazil
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00596661 on ClinicalTrials.gov